Vancouver, British Columbia--(Newsfile Corp. - July 30, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy tests ...
BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis The diagnostic delay for rare diseases varies from months to decades, and some may never ...
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The ...
As part of the transaction, Biomark Capital transferred their ownership of the HyperMed assets and made an equity-based investment in SafetySpect. The terms of the deal remain undisclosed. This ...
"Biomark Capital's acquisition of SafetySpect equity is a result of its confidence in SafetySpect's leadership, vision, and ability to scale advanced imaging solutions," said Douglas Lind, M.D., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results